Evidence map›Paper›PMID 37020794›Full record

ArticleInfection and drug resistance2023

Failure to Attain HIV Viral Suppression After Intensified Adherence Counselling-What Can We Learn About Its Factors?

James Samwel Mundamshimu, Kija Malale, Benson R Kidenya, Daniel W Gunda, Logious Bwemelo, Mwakile Mwashiuya, Salhida Shamnte Omar, Neema Mlowe, Magwa Kiyumbi, James S Ngocho and 8 more

Abstract read
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

James Samwel MundamshimuCatholic University of Health and Allied Sciences, Mwanza, Tanzania.ORCID 0000-0002-1179-7444
Kija MalaleCatholic University of Health and Allied Sciences, Mwanza, Tanzania.
Benson R KidenyaCatholic University of Health and Allied Sciences, Mwanza, Tanzania.
Daniel W GundaCatholic University of Health and Allied Sciences, Mwanza, Tanzania.
Logious Bwemelo *Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Mwakile Mwashiuya *Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Salhida Shamnte Omar *Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Neema Mlowe *Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Magwa KiyumbiCatholic University of Health and Allied Sciences, Mwanza, Tanzania.
James S NgochoKilimanjaro Christian Medical University College, Moshi, Tanzania.
Emmanuel BalandyaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0002-3707-9985
Bruno SunguyaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0003-3625-0725
Stephen E MshanaCatholic University of Health and Allied Sciences, Mwanza, Tanzania.
Kien MtetaKilimanjaro Christian Medical University College, Moshi, Tanzania.
John BartlettKilimanjaro Christian Medical University College, Mosh, Tanzania.
Eligius LyamuyaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID 0000-0002-0136-2826
Blandina Theophil MmbagaKilimanjaro Christian Medical University College, Moshi, Tanzania.ORCID 0000-0002-5550-1916
Samuel KalluvyaCatholic University of Health and Allied Sciences, Mwanza, Tanzania.

Funding

To Reach the People: Transforming Health Professions Education in Tanzania (THET)R25TW011227 · FIC · MUHIMBILI UNIVERSITY/ ALLIED HLTH SCIS · PI KAAYA, EPHATA E, KWESIGABO, GIDEON PAUL · 2018 to 2022
$3.1M
FIC NIH HHS R25 TW011227
6 · The paper itself

Abstract

Background: Introduction and expansion of antiretroviral therapy (ART) have turned the tide of HIV pandemic, thus helping people living with HIV (PLHIV) achieve viral suppression. This success may need to be complemented by intensified adherence counseling (IAC) to improve adherence to treatment. However, some PLHIV still face higher than acceptable viral loads despite being on treatment. Purpose: We investigated the factors associated with the failure to suppress HIV viral load after three months of IAC sessions. Patients and Methods: This cross-sectional study analyzed secondary data from PLHIV-attended care and treatment clinics in Mwanza between January 2018 and December 2019 who had unsuppressed VL after being on ART for at least six months. We identified PLHIV in first-line ART with viral load evaluation before receiving IAC and had viral load results done at 90 days after IAC. We conducted descriptive statistics to examine the magnitude of viral suppression. Wilcoxon signed-rank test used to compare the median viral load before and after IAC sessions, and logistic regressions predicted the factors associated with failure. Results: This study included 212 subjects. After intervention, most participants 85.9% (182) had significantly improved adherence compared to baseline. More than half 75.5% (160) of the participants had viral suppression after the intervention. Participants aged 18-25 years (AOR = 5.6, 95% CI, 1.1-29.6), unstable client during ART initiation (AOR = 0.3, 95% CI, 0.13-0.62), and poor adherence to ART (AOR = 4, 95% CI, 1.3-12.3) remained the main predictors of virological failure after IAC intervention. Conclusion: Even though virological suppression is influenced by ART adherence, the findings in this study have shown co-existence of other factors to be addressed. Unstable during ART initiation is a new factor identified in this study.

Indexed as

factorsintensified adherence counselingpeople living with HIVTanzaniavirological failure

Identifiers

PMID37020794
PMCPMC10069435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.